Prednalytics Health Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 16-11-2024
- Paid Up Capital ₹ 1.41 M
as on 16-11-2024
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.50 M
as on 16-11-2024
- Revenue -46.14%
(FY 2023)
- Profit -13.69%
(FY 2023)
- Ebitda -18.45%
(FY 2023)
- Net Worth 13.49%
(FY 2023)
- Total Assets -9.93%
(FY 2023)
About Prednalytics Health
The Company is engaged in the Internet Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.41 M.
The company currently has active open charges totaling ₹3.50 M.
Harjot Sidhu, Waseem Mohammed, Pratap Chandra, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999KA2017PTC104053
- Company No.
104053
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jun 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Prednalytics Health?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pratap Chandra  | Director | 22-Jun-2017 | Current |
| Harjot Sidhu | Director | 22-Jun-2017 | Current |
| Waseem Mohammed | Director | 22-Jun-2017 | Current |
| Praveen Potluri | Director | 10-Aug-2017 | Current |
Financial Performance of Prednalytics Health.
Prednalytics Health Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 46.14% decrease. The company also saw a substantial fall in profitability, with a 13.69% decrease in profit. The company's net worth Soared by an impressive increase of 13.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prednalytics Health?
In 2023, Prednalytics Health had a promoter holding of 72.14% and a public holding of 27.86%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
New Ramdev Health And Wellness Private LimitedActive 3 years 8 monthsPratap Chandra is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 05 Jul 2021 | ₹3.50 M | Open |
How Many Employees Work at Prednalytics Health?
Prednalytics Health has a workforce of 4 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prednalytics Health, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prednalytics Health's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
